Plain-English translation of NCT06822413 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Researchers are developing a new blood test that uses a technology called Raman spectroscopy โ which analyzes how light bounces off molecules in your blood โ combined with artificial intelligence to detect cancer early. The study will compare blood samples from healthy people, people with cancer, and people with precancerous conditions to teach the AI system to recognize patterns that signal disease. The goal is to create a simple, non-invasive tool that could catch cancer before symptoms appear.
Early detection of cancer saves lives, but current screening methods are often invasive, expensive, or miss early signs. This trial aims to develop a faster, simpler blood test that could identify multiple types of cancer at once using advanced technology.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you qualify, you would have a single blood sample taken during a routine hospital visit or medical evaluation. Your blood would be analyzed using the new light-based technology, and the researchers would use that data to train and test their artificial intelligence system. There are no follow-up visits or ongoing treatments involved โ this is a one-time donation to help develop the technology.
AI-generated summary from trial data ยท Jun 7, 2026 ยท Not medical advice
China